The U.S. Defense Logistics Agency (DLA) has awarded a delivery order worth $14,751.21 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $20,023.92 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division, which provides a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $6,715.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a prescription medication. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a $108,048.33 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML syringes. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation for the supply of STELARA 90 MG/ML SYRINGE. The $29,832.99 firm fixed-price contract has a period of performance through September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies without a set-aside designation. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide STELARA 90 MG/ML syringes. The contract, valued at $13,857.59, has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical to supply a wide...
The U.S. Defense Logistics Agency (DLA) awarded a $7,110.05 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563830621 STELARA 90 MG/ML SYRINGEML. This award is under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML syringes. The $14,179.06 firm-fixed price contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $30,858.83 for the supply of STELARA 90 MG/ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a $98,742.02 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp. The contract is for the supply of STELARA 90 MG/ML syringes, with a performance period through September 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these medical supplies to support military treatment facilities and healthcare programs. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between...